Total submissions: 3
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Labcorp Genetics |
RCV001860561 | SCV002283844 | uncertain significance | not provided | 2022-11-22 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on ACE protein function. ClinVar contains an entry for this variant (Variation ID: 813620). This variant has not been reported in the literature in individuals affected with ACE-related conditions. This variant is present in population databases (rs772888815, gnomAD 0.01%). This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 953 of the ACE protein (p.Arg953Trp). |
| Fulgent Genetics, |
RCV002497327 | SCV002775796 | uncertain significance | Microvascular complications of diabetes, susceptibility to, 3; Hemorrhage, intracerebral, susceptibility to; Renal tubular dysgenesis of genetic origin | 2024-03-14 | criteria provided, single submitter | clinical testing | |
| Department of Pediatrics, |
RCV001252820 | SCV001163963 | uncertain significance | Microcephaly | no assertion criteria provided | research |